Conference Coverage

Workshop tackles finer points of lung cancer screening

Publish date: September 10, 2015

 

EXPERT ANALYSIS FROM THE IASLC WORLD CONFERENCE

Dr. Field disclosed no relevant conflicts of interest.

Pages

Recommended Reading

Limited resection inferior for elderly with early NSCLC
MDedge Hematology and Oncology
Solid histology predicts poor survival in resected lung adenocarcinoma
MDedge Hematology and Oncology
Immune-related patterns of response present challenges
MDedge Hematology and Oncology
Vemurafenib looks promising for several nonmelanoma malignancies
MDedge Hematology and Oncology
Lung cancer in HIV-infected patients and the role of targeted therapy
MDedge Hematology and Oncology
Treatment outcomes in stage IIIA non–small-cell lung cancer in a community cancer center
MDedge Hematology and Oncology
Genomic oncology: moving beyond the tip of the iceberg
MDedge Hematology and Oncology
Adjuvant erlotinib showed no benefit in NSCLC patients
MDedge Hematology and Oncology
David Henry's JCSO podcast, July 2015
MDedge Hematology and Oncology
Nivolumab continues to offer better survival for squamous NSCLC patients
MDedge Hematology and Oncology